Regeneron Pharmaceuticals Inc. is recalling approximately 405,725 units of EYLEA (aflibercept) Injection, 2 mg (0.05mL), provided in single-dose pre-filled glass syringes. The recall was initiated following reports of syringe breakage, which leads to a lack of assurance of sterility for the medication. Because this drug is administered by intravitreal injection (directly into the eye), any compromise in the syringe's integrity or sterility poses a serious risk to patient safety.
A broken syringe or a lack of sterility can lead to serious eye infections, such as endophthalmitis, or other complications that could potentially impact a patient's vision.
Rx only; Manufactured by Regeneron Pharmaceuticals, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.